Physician profile
Scott A Wright
NPI 1043200785
$4,587.52
in general payments reported to CMS, 2019-2025
29 companies · $395 in 2025
The $395 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $415 · 2020: $65.38 · 2021: $666 · 2022: $776 · 2023: $1,304 · 2024: $968 · 2025: $395.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,666.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,666.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impulse Dynamics (USA) INC. | $1,078.12 | 2023-2024 | Optimizer, Optimizer |
| Janssen Pharmaceuticals, INC | $615.48 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $516.39 | 2019-2025 | |
| Pfizer INC. | $302.46 | 2020-2025 | |
| Abbott Laboratories | $298.45 | 2024-2025 | Cardiomems |
| Merck Sharp & Dohme LLC | $252.35 | 2021-2024 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $239.26 | 2021-2025 | Lifevest |
| Novo Nordisk INC | $170.00 | 2021-2024 | Rybelsus, Ozempic |
| Amgen INC. | $120.13 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $116.02 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $108.98 | 2019-2023 | Jardiance |
| Alnylam Pharmaceuticals INC. | $107.59 | 2021-2023 | Onpattro |
| Gilead Sciences, INC. | $98.34 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $89.40 | 2019-2023 | Camzyos, Eliquis |
| Cardiovascular Systems INC. | $52.33 | 2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $50.81 | 2019-2021 | |
| Abiomed | $49.95 | 2025 | |
| Lexicon Pharmaceuticals, INC. | $45.61 | 2023 | Inpefa |
| Irhythm Technologies, INC. | $38.36 | 2024 | Zio Monitor, Zio Xt Patch |
| Philips North America LLC | $35.04 | 2022-2023 | |
| Heartflow, INC. | $32.33 | 2024 | |
| Vanda Pharmaceuticals INC. | $27.87 | 2021 | |
| Siemens Medical Solutions USA, INC. | $27.70 | 2023-2024 | Artis Icono Biplane, Artis Icono Floor |
| Bayer Healthcare Pharmaceuticals INC. | $26.24 | 2022 | |
| Atricure, INC. | $24.52 | 2022 | |
| Lundbeck LLC | $18.24 | 2019 | |
| Jazz Pharmaceuticals INC. | $17.06 | 2019 | |
| Cmp Pharma, INC. | $14.26 | 2022 | |
| Vifor Pharma, INC. | $14.23 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.